drugset / Trial / NCT04040127

Residual Dental Pulp Tissue and Cord Blood Stem Cells

NCT04040127

RandomizedParallel-groupDouble-blindTreatment

Summary

The experiments outlined in this proposal are designed to test the hypothesis that the in vivo injection of cord blood stem cells (InvitRx®) into the root canal system will facilitate teeth initially diagnosed with irreversible pulpitis, to form normal healthy pulpal tissue.

Timeline

Start
2019-09-01
Primary completion
2020-01-15
Completion
2020-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Cord blood stem cells Cell therapy 1 ml Other
Subject Cord blood stem cells Cell therapy 3e+07 cells Other

Indications